Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Article
  • Published:

Absence of damaging effects of stem cell donation in unrelated donors assessed by FISH and gene variance screening

Bone Marrow Transplantation volume 55, pages 1290–1296 (2020)Cite this article

Subjects

Astract

Granulocyte–Colony-Stimulating factor (G-CSF) is currently the standard mobilising agent for peripheral blood stem cell (PBSC) donation. Concerns that it may trigger chromosome aberrations similar to those observed in leukaemia patients were refuted but long-term effects of G-CSF mobilisation on genome integrity remains unclear. In the setting of a multi-centre clinical trial we screened blood samples from 50 PBSC donors at cellular and gene level for aberrations common in haematological malignancies using fluorescence in situ hybridisation (FISH) and next generation sequencing (NGS) assays. Analysis of samples collected before, on the day of donation, 90 and 180 days after G-CSF admission confirmed the absence of short-term effects in PBSC donors on both quiescent and dividing cells. This data did not differ from the results of 50 individuals tested 3–5 years after bone marrow donation and 50 healthy persons. NGS using a panel targeting 54 genes recurrently affected in myeloid disorders (TruSight Myeloid panel, Illumina) showed that the gene profiles of samples from 48 PBSC donors remained stable throughout the study period. These data strongly indicate absence of detrimental effects on the genome integrity caused by PBSC donation.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: Gene variants detected using TruSight Myeloid panel in G-CSF mobilised donors.

Similar content being viewed by others

References

  1. Anderlini P, Przepiorka D, Champlin R, Körbling M. Biologic and clinical effects of granulocyte colony-stimulating factor in normal individuals. Blood 1996;88:2819–25.

    Article  CAS  Google Scholar 

  2. Pamphilon D, Nacheva E, Navarrete C, Madrigal A, Goldman J. The use of granulocyte-colony-stimulating factor in volunteer unrelated hemopoietic stem cell donors. Transfusion 2008;48:1495–501.

    Article  Google Scholar 

  3. Battiwalla M, McCarthy P. Filgrastim support in allogeneic HSCT for myeloid malignancies: a review of the role of G-CSF and the implications for current practice. Bone Marrow Transpl. 2009;43:351–6.

    Article  CAS  Google Scholar 

  4. Beekman R, Touw IP. G-CSF and its receptor in myeloid malignancy. Blood 2010;115:5131–6.

    Article  CAS  Google Scholar 

  5. Martino M, Fedele R, Massara E, Recchia A, Irrera G, Morabito F. Long-term safety of granulocyte colony-stimulating factor in normal donors: is it all clear? Expert Opin Biol Ther. 2012;12:609–21.

    Article  CAS  Google Scholar 

  6. Nagler A, Korenstein-Ilan A, Amiel A, Avivi L. Granulocyte colony-stimulating factor generates epigenetic and genetic alterations in lymphocytes of normal volunteer donors of stem cells. Exp Hematol. 2004;32:122–30.

    Article  CAS  Google Scholar 

  7. Avalos BR, Lazaryan A, Copelan EA. Can G-CSF cause leukaemia in hematopoietic stem cell donors? Biol Blood Marrow Transpl. 2011;17:1739–46.

    Article  CAS  Google Scholar 

  8. Shaw B, Confer D, Hwang W, Pulsipher M. A review of the genetic and long-term effects of G-CSF injections in healthy donors: a reassuring lack of evidence for the development of haematological malignancies. Bone Marrow Transpl. 2015;50:334–40.

    Article  CAS  Google Scholar 

  9. Marmier-Savet C, Larosa F, Legrand F, Witz B, Michallet M, Ranta D, et al. G-CSF-induced aneuploidy does not affect CD34+ cells and does not require cell division. Blood 2010;115:910–1.

    Article  CAS  Google Scholar 

  10. Hirsch B, Oseth L, Cain M, Trader E, Pulkrabek S, Lindgren B, et al. Effects of granulocyte-colony stimulating factor on chromosome aneuploidy and replication asynchrony in healthy peripheral blood stem cell donors. Blood 2011;118:2602–8.

    Article  CAS  Google Scholar 

  11. Mitelman F, Heim S. Cancer Cytogenetics: chromosomal and molecular genetic aberrations of tumour cells. 4th Edition. Wiley-Blackwell. 2015. p.1–10.

  12. Forbes SA, Bindal N, Bamford S, Cole C, Kok C, Beare D, et al. COSMIC: mining complete cancer genomes in the Catalogue of Somatic Mutations in Cancer. Nucleic Acids Res. 2011;39(supl. 1):D945–50.

    Article  CAS  Google Scholar 

  13. Network C, Weinstein JN, Collisson EA, Mills GB, Shaw KR, Ozenberger BA, et al. The Cancer Genome Atlas Pan-Cancer analysis project. Nat Genet. 2013;45:1113–20.

    Article  Google Scholar 

  14. Nangalia J, Mitchell E, Green AR. Clonal approaches to understanding the impact of mutations on hematologic disease development. Blood 2019;133:1436–45.

    Article  CAS  Google Scholar 

  15. Virgili A, Nacheva EP. Genomic amplification of BCR/ABL1 and a region downstream of ABL1 in chronic myeloid leukaemia: a FISH mapping study of CML patients and cell lines. Mol Cytogenet. 2010;3:15.

    Article  Google Scholar 

  16. Lek M, Karczewski KJ, Minikel EV, Samocha KE, Banks E, Fennell T, et al. Analysis of protein-coding genetic variation in 60,706 humans. Nature 2016;536:285–91.

    Article  CAS  Google Scholar 

  17. Stratton MR. Journeys into the genome of cancer cells. EMBO Mol Med. 2013;5:169–72.

    Article  CAS  Google Scholar 

  18. Steensma DP. Clinical Implications of Clonal Haematopoiesis. Mayo Clin Proc. 2018;93:1122–30.

    Article  Google Scholar 

  19. Bodian DL, McCutcheon JN, Kothiyal P, Huddleston KC, Iyer RK, Vockley JG, et al. Germline variation in cancer-susceptibility genes in a healthy, ancestrally diverse cohort: implications for individual genome sequencing. PloS one. 2014;9:e94554.

    Article  Google Scholar 

  20. Sperling AS, Gibson CJ, Ebert BL. The genetics of myelodysplastic syndrome: from clonal haematopoiesis to secondary leukaemia. Nat Rev Cancer. 2017;17:5–19.

    Article  CAS  Google Scholar 

  21. Tomasetti C, Li L, Vogelstein B. Stem cell divisions, somatic mutations, cancer aetiology, and cancer prevention. Science. 2017;355:1330–4.

    Article  CAS  Google Scholar 

  22. Boneva T. Prognostic significance of gene mutations in MDS depends on the loci of gene variances. EHA Library 2017;180952. (Abstract E1176).

  23. Dewald G, Noonan K, Spurbeck J, Johnson D. T-lymphocytes with 7;14 translocations: frequency of occurrence, breakpoints, and clinical and biological significance. Am J Hum Genet. 1986;38:520–32.

    CAS  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

We are grateful to all the donors who agreed to take part in this study and the nursing staff who assisted us. We also thank all the office staff at the British Bone Marrow Registry (BBMR) and at Anthony Nolan, for their support in tracing the samples. The laboratory investigations were performed by A. Virgili, K. Gancheva, L. Rai, G. Uka and S. Phyo. Chugai, Amgen and Illumina, the Royal Free Charity, the BBMDA Charity, Anthony Nolan and the BBMR through NHSBT provided the financial support for this study.

Author information

Author notes

  1. Deceased: J. Goldman

Authors and Affiliations

  1. UCL Cancer Institute, London, UK

    E. Nacheva & S. Mackinnon

  2. HSL Analytical LLP, OncoGenomics, Halo Building, Level 6, 1 Mabledon Place, London, WC1H 9AX, UK

    E. Nacheva

  3. Anthony Nolan Research Institute, The Royal Free Hospital, Pond Street, London, NW3 2QG, UK

    T. Ahyee, J. Addada, B. E. Shaw & A. Madrigal

  4. NHSBT British Bone Marrow Register (BBMR) and NHS Cord Blood Bank, Charcot Road, Colindale, London, NW9 5BG, UK

    C. Navarette, D. Pamphilon, F. Regan & R. Pawson

  5. Centre for Haematology, Faculty of Medicine, BC2, Hammersmith Hospital, Imperial College Hammersmith Campus, London, UK

    R. Szydlo & J. Goldman

  6. Centre for International Blood and Marrow Transplant Research, Milwaukee, WI, USA

    B. E. Shaw

Authors
  1. E. Nacheva
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. T. Ahyee
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. J. Addada
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. C. Navarette
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. D. Pamphilon
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. F. Regan
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. R. Pawson
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. R. Szydlo
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. J. Goldman
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. S. Mackinnon
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. B. E. Shaw
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. A. Madrigal
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to E. Nacheva.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary information

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Nacheva, E., Ahyee, T., Addada, J. et al. Absence of damaging effects of stem cell donation in unrelated donors assessed by FISH and gene variance screening. Bone Marrow Transplant 55, 1290–1296 (2020). https://doi.org/10.1038/s41409-020-0945-y

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41409-020-0945-y

Search

Advanced search

Quick links